Literature DB >> 2833519

Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.

J Baudier1, R D Cole.   

Abstract

Binding between the microtubule-associated tau protein and S100b protein was demonstrated by affinity chromatography and cross-linking experiments and was manifested in the effect of S100b on tau protein phosphorylation by protein kinase II. All three expressions of the binding showed that S100b discriminates among the four species of tau, revealing for the first time that the different kinds of tau may differ functionally. Noncovalent interaction between tau and S100b depended on the presence of Ca2+ or Zn2+ and resulted in total inhibition of tau phosphorylation by protein kinase II. In the absence of reducing agent, covalent binding studies between Cys84 beta in the carboxyl-terminal region of the S100b-beta subunit and tau proteins confirmed interactions between the two proteins. It is suggested that the homologous calcium-binding domain that characterizes the carboxyl terminus of S100 and the tubulin subunit may be responsible for the common interaction of both proteins with tau proteins. The physicochemical relationship between S100 subunits and p11, the subunit of a substrate for tyrosine kinase, and their similarity in interaction with protein kinase substrates are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833519

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.

Authors:  R R Rustandi; D M Baldisseri; A C Drohat; D J Weber
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

3.  S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12.

Authors:  Juliana Karl Frizzo; Francine Tramontina; Erica Bortoli; Carmen Gottfried; Rodrigo B Leal; Imre Lengyel; Rosario Donato; Peter R Dunkley; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

4.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 5.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

6.  Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments.

Authors:  M Goebeler; J Roth; C van den Bos; G Ader; C Sorg
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 7.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

8.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07

9.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21

10.  The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus.

Authors:  D R Ziegler; C E Innocente; R B Leal; R Rodnight; C A Gonçalves
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.